For: | Li JM, Chen H. Recurrent hypotension induced by sacubitril/valsartan in cardiomyopathy secondary to Duchenne muscular dystrophy: A case report. World J Clin Cases 2019; 7(23): 4098-4105 [PMID: 31832414 DOI: 10.12998/wjcc.v7.i23.4098] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v7/i23/4098.htm |
Number | Citing Articles |
1 |
Alessandra Arcudi, Marco Di Francesco, Daniele Rodolico, Domenico D'Amario. Angiotensin receptor‐neprilysin inhibitor in symptomatic patients with Duchenne dilated cardiomyopathy: A primetime. ESC Heart Failure 2022; 9(5): 3639 doi: 10.1002/ehf2.13963
|
2 |
R. Quinlivan, B. Messer, P. Murphy, R. Astin, R. Mukherjee, J. Khan, A. Emmanuel, S.C. Wong, R. Kulshresha, T. Willis, J. Pattni, D. Willis, A. Morgan, K. Savvatis, R. Keen, J. Bourke, C. Marini Bettolo, C. Hewamadduma. Adult North Star Network (ANSN): Consensus Guideline For The Standard Of Care Of Adults With Duchenne Muscular Dystrophy. Journal of Neuromuscular Diseases 2021; 8(6): 899 doi: 10.3233/JND-200609
|
3 |
Metoprolol tartrate/sacubitril/valsartan. Reactions Weekly 2020; 1791(1): 173 doi: 10.1007/s40278-020-75018-9
|
4 |
John Bourke, Cathy Turner, William Bradlow, Ashish Chikermane, Caroline Coats, Matthew Fenton, Maria Ilina, Alexandra Johnson, Stam Kapetanakis, Lisa Kuhwald, Adrian Morley-Davies, Ros Quinlivan, Konstantinos Savvatis, Marianela Schiava, Zaheer Yousef, Michela Guglieri. Cardiac care of children with dystrophinopathy and females carrying DMD-gene variations. Open Heart 2022; 9(2): e001977 doi: 10.1136/openhrt-2022-001977
|
5 |
Pankaj Jariwala, Kartik Jadhav, Saket Khetan. Effectiveness and Safety of Sacubitril/Valsartan for Heart Failure with Reduced Ejection Fraction Secondary to Duchenne Muscular Dystrophy-Associated Cardiomyopathy. Journal of The Indian Academy of Echocardiography & Cardiovascular Imaging 2023; 7(1): 31 doi: 10.4103/jiae.jiae_17_22
|
6 |
Yan Shen, Il-man Kim, Yaoliang Tang. Identification of Novel Gene Regulatory Networks for Dystrophin Protein in Vascular Smooth Muscle Cells by Single-Nuclear Transcriptome Analysis. Cells 2023; 12(6): 892 doi: 10.3390/cells12060892
|
7 |
Samuel G. Wittekind, Chet R. Villa. Cardiac medication management in Duchenne muscular dystrophy. Pediatric Pulmonology 2021; 56(4): 747 doi: 10.1002/ppul.25175
|
8 |
Harshi Saxena, Neal L. Weintraub, Yaoliang Tang. Potential therapeutic targets for hypotension in duchenne muscular dystrophy. Medical Hypotheses 2024; 185: 111318 doi: 10.1016/j.mehy.2024.111318
|
9 |
Saba Gharibi, Cyrille Vaillend, Angus Lindsay. The unconditioned fear response in vertebrates deficient in dystrophin. Progress in Neurobiology 2024; 235: 102590 doi: 10.1016/j.pneurobio.2024.102590
|